Japan Designates Valemetostat for Accelerated Development to Treat PTCL
News
The Japan Ministry of Health, Labour and Welfare (MHLW) has granted Sakigake Designation to valemetostat, an investigational treatment for adult patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). The designation is ... Read more